Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor

US Patent RE46284 · Granted Jan 24, 2017

Assignee

Inventors

View full patent text on Google Patents →